요약
A new artificial intelligence-led approach to antiviral drug discovery has produced compounds that inhibit a human enzyme exploited by viruses, pointing towards a different way of tackling viral disease. The post AI-designed antiviral compounds pass first lab…
본문
Viruses present drug developers with an enduring problem. Evolution can alter viral proteins, potentially reducing the effectiveness of medicines designed to attack them directly. One alternative is …